Barclays lowered the firm’s price target on Amdocs (DOX) to $92 from $111 and keeps an Overweight rating on the shares. The firm updated the company’s model post the earnings report.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on DOX: